Lexeo Raises $100m To Advance CNS Candidates, Validate Cardiac Gene Therapies
Start-Up Has Brought In $185m In Less Than A Year
Lexeo will take its first gene therapy for a rare cardiomyopathy into the clinic within the next few months • Source: Alamy 
